The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; 5 pharmaceutical formulation of same; and method of use.
申请公布号
AU2016244281(A1)
申请公布日期
2016.11.03
申请号
AU20160244281
申请日期
2016.10.13
申请人
Celgene Avilomics Research, Inc.
发明人
Petter, Russell C.;Jewell, Charles F.;Lee, Kwangho;Medikonda, Aravind Prasad;Niu, Deqiang;Qiao, Lixin;Singh, Juswinder;Zhu, Zhendong
